Uncovering the Clinical Relevance of Unclassified Variants in DNA Repair Genes: a Focus on Negative Tunisian Cancer Families

Overview

Journal Front Genet

Date 2024 Feb 5

PMID 38313678

Authors

Maroua Boujemaa

Fatma Nouira

Nouha Jandoubi

Nesrine Mejri

Hanen Bouaziz

Cherine Charfeddine

Sonia Ben Nasr

Soumaya Labidi

Houda El Benna

Yosra Berrazega

Haifa Rachdi

Nouha Daoud

Farouk Benna

Abderrazek Haddaoui

Sonia Abdelhak

Mohamed Samir Boubaker

Hamouda Boussen

Yosr Hamdi

Affiliations

Soon will be listed here.

Abstract

Recent advances in sequencing technologies have significantly increased our capability to acquire large amounts of genetic data. However, the clinical relevance of the generated data continues to be challenging particularly with the identification of Variants of Uncertain Significance (VUSs) whose pathogenicity remains unclear. In the current report, we aim to evaluate the clinical relevance and the pathogenicity of VUSs in DNA repair genes among Tunisian breast cancer families. A total of 67 unsolved breast cancer cases have been investigated. The pathogenicity of VUSs identified within 26 DNA repair genes was assessed using different prediction tools including SIFT, PolyPhen2, Align-GVGD and VarSEAK. Effects on the 3D structure were evaluated using the stability predictor DynaMut and molecular dynamics simulation with NAMD. Family segregation analysis was also performed. Among a total of 37 VUSs identified, 11 variants are likely deleterious affecting genes. The variant, c.3254dupT, is novel and seems to be associated with increased risk of breast, endometrial and colon cancer. Moreover, c.6115G>A in and c.592+3A>T in were of keen interest identified in families with multiple breast cancer cases and their familial cosegregation with disease has been also confirmed. In addition, functional analyses revealed that the variant may lead to protein immobilization and rigidification thus decreasing its activity. We have also shown that and variants may lead to protein destabilization and alteration of the structure compactness which may affect FANCC and FANCG protein activity. Our findings revealed that VUSs in DNA repair genes might be associated with increased cancer risk and highlight the need for variant reclassification for better disease management. This will help to improve the genetic diagnosis and therapeutic strategies of cancer patients not only in Tunisia but also in neighboring countries.

References

Berman H, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H . The Protein Data Bank. Nucleic Acids Res. 1999; 28(1):235-42. PMC: 102472. DOI: 10.1093/nar/28.1.235. View

Vijai J, Topka S, Villano D, Ravichandran V, Maxwell K, Maria A . A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer. Cancer Discov. 2016; 6(11):1267-1275. PMC: 5614601. DOI: 10.1158/2159-8290.CD-16-0487. View

Tavtigian S, Deffenbaugh A, Yin L, Judkins T, Scholl T, Samollow P . Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2005; 43(4):295-305. PMC: 2563222. DOI: 10.1136/jmg.2005.033878. View

Schwarz J, Rodelsperger C, Schuelke M, Seelow D . MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010; 7(8):575-6. DOI: 10.1038/nmeth0810-575. View

Chiang J, Chia T, Yuen J, Shaw T, Li S, Ishak N . Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical Care. JCO Precis Oncol. 2022; 5:577-584. DOI: 10.1200/PO.20.00399. View

Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K . Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015; 24(8):2125-37. PMC: 4375422. DOI: 10.1093/hmg/ddu733. View

Desvignes J, Bartoli M, Delague V, Krahn M, Miltgen M, Beroud C . VarAFT: a variant annotation and filtration system for human next generation sequencing data. Nucleic Acids Res. 2018; 46(W1):W545-W553. PMC: 6030844. DOI: 10.1093/nar/gky471. View

Desmet F, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C . Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009; 37(9):e67. PMC: 2685110. DOI: 10.1093/nar/gkp215. View

Vaser R, Adusumalli S, Leng S, Sikic M, Ng P . SIFT missense predictions for genomes. Nat Protoc. 2015; 11(1):1-9. DOI: 10.1038/nprot.2015.123. View

10.

de Voer R, Hahn M, Mensenkamp A, Hoischen A, Gilissen C, Henkes A . Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer. Sci Rep. 2015; 5:14060. PMC: 4566092. DOI: 10.1038/srep14060. View

11.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

12.

Fang C, Wu H, Zhang M, Liu J, Zhang G . Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets. Front Cell Dev Biol. 2020; 8:160. PMC: 7142266. DOI: 10.3389/fcell.2020.00160. View

13.

Rodrigues C, Pires D, Ascher D . DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018; 46(W1):W350-W355. PMC: 6031064. DOI: 10.1093/nar/gky300. View

14.

Spurdle A, Healey S, Devereau A, Hogervorst F, Monteiro A, Nathanson K . ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Hum Mutat. 2011; 33(1):2-7. PMC: 3240687. DOI: 10.1002/humu.21628. View

15.

Fornasarig M, Magris R, De Re V, Bidoli E, Canzonieri V, Maiero S . Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis. Int J Mol Sci. 2018; 19(6). PMC: 6032275. DOI: 10.3390/ijms19061682. View

16.

Suszynska M, Klonowska K, Jasinska A, Kozlowski P . Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes. Gynecol Oncol. 2019; 153(2):452-462. DOI: 10.1016/j.ygyno.2019.01.027. View

17.

Cohen-Haguenauer O . [Hereditary predisposition to breast cancer (1): genetics]. Med Sci (Paris). 2019; 35(2):138-151. DOI: 10.1051/medsci/2019003. View

18.

Del Valle J, Rofes P, Moreno-Cabrera J, Lopez-Doriga A, Belhadj S, Vargas-Parra G . Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. Cancers (Basel). 2020; 12(4). PMC: 7226125. DOI: 10.3390/cancers12040829. View

19.

Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

20.

Sheehan M, Heald B, Yanda C, Kelly E, Grobmyer S, Eng C . Investigating the Link between Lynch Syndrome and Breast Cancer. Eur J Breast Health. 2020; 16(2):106-109. PMC: 7138356. DOI: 10.5152/ejbh.2020.5198. View